Pseudomonas aeruginosa produces, under conditions of iron limitation, a high-affinity siderophore, pyoverdine (PVD), which is recognized at the level of the outer membrane by a specific TonB-dependent receptor, FpvA. So far, for P. aeruginosa, three different PVDs, differing in their peptide chain, have been described (types I-III), but only the FpvA receptor for type I is known. Two PVD-producing P. aeruginosa strains, one type II and one type III, were mutagenized by a mini-TnphoA3 transposon. In each case, one mutant unable to grow in the presence of the strong iron chelator ethylenediaminedihydroxyphenylacetic acid (EDDHA) and the cognate PVD was selected. The first mutant, which had an insertion in the pvdE gene, upstream of fpvA, was unable to take up type II PVD and showed resistance to pyocin S3, which is known to use type II FpvA as receptor. The second mutant was unable to take up type III PVD and had the transposon insertion in fpvA. Cosmid libraries of the respective type II and type III PVD wild-type strains were constructed and screened for clones restoring the capacity to grow in the presence of PVD. From the respective complementing genomic fragments, type II and type III fpvA sequences were determined. When in trans, type II and type III fpvA restored PVD production, uptake, growth in the presence of EDDHA and, in the case of type II fpvA, pyocin S3 sensitivity. Complementation of fpvA mutants obtained by allelic exchange was achieved by the presence of cognate fpvA in trans. All three receptors posses an N-terminal extension of about 70 amino acids, similar to FecA of Escherichia coli, but only FpvAI has a TAT export sequence at its N-terminal end.
INTRODUCTION
Most Gram-negative bacteria with an aerobic lifestyle are confronted with the problem of iron(III) insolubility and therefore excrete iron-chelating molecules, termed siderophores (Neilands, 1995; Ratledge & Dover, 2000) .
Siderophores are recognized by specific receptors, which function as gated porin channels in concert with the TonB protein that energizes the receptor protein (Ratledge & Dover, 2000) . This protein family is characterized by a large C-terminal domain consisting of 22 antiparallel b-strands, which form a b-barrel that spans the outer membrane (Koebnik et al., 2000) . In contrast to outer-membrane porins, TonB-dependent outer-membrane proteins contain an additional domain known as a 'cork' or 'plug' that transiently blocks the channel formed by the b-barrel domain and, by using energy transduced by TonB, selectively allows uptake of cognate siderophore-iron complexes (Ferguson et al., 1998) .
Pseudomonas aeruginosa produces the siderophore pyoverdine (PVD), which is composed of a dihydroxyquinoline chromophore and a variable peptide chain (Meyer, 2000) . Three structurally different PVDs (with different peptide chains) have been identified from P. aeruginosa strains (Cornelis et al., 1989; Meyer et al., 1997; De Vos et al., 2001) , each recognized at the level of the outer membrane by a specific receptor (Cornelis et al., 1989) . The receptor for P. aeruginosa PAO1 PVD (type I PVD) has been intensively characterized using physiological, immunological and molecular approaches (among others, Poole et al., 1993; Schalk et al., 2002) . PVD is essential for the virulence of P. aeruginosa in mouse models (Meyer et al., 1996; Handfield et al., 2000) . It has been shown previously that P. aeruginosa strains producing type II PVD receptor are killed by pyocin S3, a P. aeruginosa bacteriocin (Baysse et al., 1999; Michel-Briand & Baysse, 2002) . Mutants that failed to produce the receptor were found to be unable to take up PVD and became resistant to pyocin S3 (Baysse et al., 1999) . In this work, we describe the isolation of receptornegative mutants for type II and type III PVDs, respectively, their physiological characterization, the cloning of the respective receptors by complementation and their analysis at the molecular level.
METHODS
Bacterial strains and plasmids. Bacterial strains and plasmids used in this study are shown in Table 1 .
Transposon mutagenesis. Mutagenesis of P. aeruginosa 7NSK2 (Höfte et al., 1990) was done by biparental mating with the donor strain Escherichia coli SM10 (l pir) containing the suicide delivery system pUT ) and the transposon miniTnphoA3 as described previously (Pattery et al., 1999) . Transconjugants were selected on Casamino acid medium (CAA) plates supplemented with appropriate antibiotics [100 mg gentamycin (Gm) l 21 ; 10 mg tetracycline l 21 ]. Candidates for receptor mutants were first selected on CAA plus 0?5 mg ethylenediaminedihydroxyphenylacetic acid (EDDHA) ml 21 , and CAA plus 0?5 mg EDDHA ml 21 and PVDII (50 mM). Mutants deficient for FpvAII were confirmed by their resistance to pyocin S3 (Baysse et al., 1999) . The same strategy was used for the selection of PVD receptor mutants of clinical isolate P. aeruginosa 59.20, a type III PVD producer , with the exception of the pyocin S3 test.
Purification of PVDs. For growth-stimulation experiments, PVDs were partially purified from 10 ml CAA culture supernatants, while for uptake experiments they were purified by a more elaborate method, as described previously . The amount of PVD present in the solution was estimated by measuring the absorbance at 400 nm .
Physiological characterization. Growth stimulation by the different PVDs on CAA plus EDDHA was done on agar plates by streaking, parallel to the wild-type, one PVD biosynthesis mutant (as positive control) and the candidate receptor-negative mutant. Growth stimulation was recorded after one day, and the plates were photographed using a Fuji Digital camera. For more accurate analysis, growth was assessed in microtitre plates (300 ml of culture), which were incubated for 48 h at 37˚C in a Bio-Screen incubator (Life Technologies), using the following parameters: shaking for 30 s per 3 min and readings recorded every 10 min (De Vos et al., 2001) . Fe-labelled PVDs was done as described previously (Munsch et al., 2000) .
Analysis of outer-membrane proteins. Outer-membrane proteins from bacteria grown under iron-limiting conditions (CAA) were prepared as described by Mizuno & Kageyama (1978) . The protein content of the outer-membrane preparations was determined by the Lowry method, and analysed by SDS-PAGE (10 % polyacrylamide).
Inverse-PCR (IPCR) characterization of mutants. Genomic DNA was digested with PstI (or SmaI or EcoRV) and ligations were performed according to standard methods (Sambrook et al., 1989) . IPCR of circularized PstI-digested DNAs of the mutants was performed using the primers PhoA5 and GM1 (Table 2) . Nested-PCR (NPCR) was done after the first amplification using primers PhoA4 and Gm2. IPCR and NPCR were done for 30 cycles (30 s at 94˚C for the denaturation, 30 s at 55˚C for annealing and 4 min at 72˚C for the elongation), preceded by one cycle of denaturation of 50 s, and terminated by one cycle of elongation of 10 min. The NPCRamplified fragments were cloned in the vector pCR2.1 (TA-cloning kit; Invitrogen).
Construction of genomic libraries and complementation.
A genomic library of 20-25 kb PstI partially digested genome fragments of the wild-type strain 59.20 was constructed in the cosmid pRG930 (Van den Eede et al., 1992) , using the Gigapack III Gold kit (Stratagene). Two-thousand clones were selected on Luria-Bertani agar supplemented with spectinomycin (50 mg ml 21 ) and streptomycin (20 mg ml
21
). Triparental mating between pooled clones of the bank, a helper E. coli strain containing plasmid pRK 2013 and mutant 59.20-18B3 was performed in order to complement strain 59.20-18B3. The complemented mutant was selected on CAA plus EDDHA. The cosmid clone 2E7 that complemented the mutant was isolated from the library and the cosmid DNA was purified.
For strain 7NSK2, a Sau3AI genomic library of 7NSK2 was constructed as described previously and screened by colony blotting (Dig-System; Roche).
Generation of DfpvA mutants by allelic exchange. The wildtype fpvAII gene was amplified using as the template wild-type P. aeruginosa 7NSK2 DNA and primers FpvAII-R1 and FpvAII-R2 ( Table 2 ). The amplification reaction was carried out by using 50 ng of the template and TaKaRa Ex Taq polymerase (TaKaRa Biomedicals) in a reaction mixture of 50 ml. The PCR product was purified with the QIAQuick gel extraction Kit (QIAGEN). After the addition of dATP (Sambrook et al., 1989) , the PCR fragment was cloned into the EcoRI site of the pCR2.1 vector (Invitrogen), following the protocol supplied by the manufacturer, and one clone was selected for sequence and restriction analyses.
The constructed plasmid was digested in a unique SalI restriction site and the overhangs were filled using T4 DNA polymerase according to the manufacturer's instructions (Fermentas). This plasmid was ligated to a Gm cassette (Baysse et al., 2001 ) and transformed into DH5a cells. Plasmid DNA of one transformant was analysed by restriction digestion to ensure that the Gm cassette was inserted into the fpvAII gene. This DNA was used as template for PCR amplification using 50 ng of template, 5 ml of 106 PCR buffer, 10 ml Q solution (QIAGEN), 4 ml of 2?5 mM dNTPs, 1 ml of 20 mM of each primer (R1 and R2) and 2 ml Proof Start enzyme (QIAGEN) in a master mix of 50 ml.
The PCR fragment was purified using the QIAQuick gel extraction Kit (QIAGEN) according to the manufacturer's instructions. This fragment, containing the DfpvAII gene, was then ligated into EcoRI-restricted pBR325 and transformed into DH5a with selection of chloramphenicol-and Gm-resistant colonies. Screening of clones was done by colony PCR using primers Gm1 and Gm2. The PCR was carried out by using 4 ml of 2?5 mM dNTPs, 1?5 ml of 50 mM MgCl 2 , 1 ml of 20 mM of each primer and 0?25 ml Taq polymerase (5 U ml
). Additional screening was done by restriction analysis. The selected clones were used to transform E. coli GJ23 cells before mobilization of the disrupted fpvAII gene by conjugation into P. aeruginosa 7NSK2. Recombinants were selected by their resistance to Gm (100 mg ml 21 ) and spectinomycin (50 mg ml 21 ).
The fpvAIII ORF (2445 bp) from P.aeruginosa 59.20 was similarly amplified using primers FpvAIII-F and FpvAIII-R, and cloned into pCR2.1 using the TA-cloning kit (Invitrogen). The same Gm R cassette was inserted blunt into the SnaBI site (1458 bp downstream from the start of the cloned ORF). Since double crossover recombinants should be Gm R but sensitive to tetracycline, clones not growing on tetracycline (100 mg ml 21 ) were selected.
Sequence determination and analyses. Sequencing was realized by Eurogentec or Genome Express and the sequences were compared using the BLASTX algorithm against the NCBI database and the P. aeruginosa database (http://www.pseudomonas.com). For determination of ORFs, the GENE COMPARE software was utilized (Applied Maths). The multiple-sequence alignment of FpvAI, FpvAII and FpvAIII was based on a larger non-redundant CLUSTAL W alignment that included~100 sequences from other known or putative TonB-dependent receptor proteins. The cork region was realigned using the HMMER 2 algorithm (http://hmmer.wustl.edu/) based on a profile generated from a structural alignment of E. coli FhuA, FepA and FecA. Subsequently, the alignment was edited This study E. coli DH5a supE44 DlacU169 (w80 lacZDM15 recA hsdR17 recA1 endA1 gyrA96 thi-1 relA1)
Hanahan ( manually to ensure optimal gap placement and correct alignment of highly conserved residues.
Subtractive hybridization. Suppression subtractive hybridization was carried out using the CLONTECH PCR-Select Bacterial Genome Subtraction Kit (Clontech) as recommended by the supplier and as described recently (Parsons et al., 2002) . The subtraction library was screened by sequencing of PCR amplicons from individual clones. Sequences obtained were used in BLAST searches at the Pseudomonas Genome Project web-site (http://www.pseudomonas. com) to determine their presence or absence from the PAO1 genome. Tester-specific sequences were further analysed using BLASTN and BLASTX searches of the database using the NCBI web-site (http://www.ncbi.nlm.nih.gov).
Electrospray-ionization tandem mass spectrometry (ESI-MS/ MS) and N-terminal sequence analysis. Gel pieces were washed with 50 mM ammonium bicarbonate (pH 7?8)/acetonitrile (60 : 40) for 1 h at room temperature. The solution was removed and the bands were vacuum-dried for 25 min in a SpeedVac (Savant Instruments). Gel pieces were rehydrated in 12 ml of modified sequencing-grade trypsin (Promega; 12 ng ml 21 in 50 mM ammonium bicarbonate) at 4˚C for 1 h. Excess trypsin solution was removed and the gel pieces suspended in 20-30 ml of 50 mM ammonium bicarbonate and incubated overnight at 37˚C. Eluted peptides were concentrated and de-salted using C 18 Zip-Tips (Millipore) and were eluted in 1-2 ml of 50 % methanol/1 % formic acid directly into borosilicate nanoelectrospray needles (Micromass). ESI-MS/MS was performed using a Q-Tof hybrid quadrupole/orthogonal-acceleration time-of-flight (TOF) mass spectrometer (Micromass). Nanoelectrospray needles containing the sample were mounted in the source and stable flow was obtained using capillary voltages of 900-1200 V. Precursor ion scans were performed to detect mass : charge (m/z) values for peptides within the mixture. The m/z value of each individual precursor ion was selected for fragmentation and collided with argon gas using collision energies of 18-30 eV. Fragment ions (corresponding to the loss of amino acids from the precursor peptide) were recorded and processed using MASSLYNX version 3.4 (Micromass). Amino acid sequences were deduced by the mass differences between y-or b-ion 'ladder' series using the program MASSSEQ (Micromass) and confirmed by manual interpretation. N-terminal Edman sequencing was performed as described previously (Nouwens et al., 2000) .
Multiplex PCR for the identification of fpvAI, fpvAII and fpvAIII. Six primers were designed for the simultaneous amplification of the different fpvA genes: primers 1F and 1R for the amplification of a 326 bp fragment corresponding to fpvAI; primers 2F and 2R for the amplification of an 897 bp fragment corresponding to fpvAII; and primers 3F and 3R for the amplification of a 506 bp fragment corresponding to fpvAIII. The following conditions were used: first a denaturation at 94˚C for 3 min, followed by 30 cycles with denaturation at 94˚C for 30 s, annealing at 55˚C for 30 s and elongation at 72˚C for 30 s, and terminating with a last cycle at 72˚C for 10 min.
Pyocin S3 susceptibility assay. A total cell lysate containing pyocin S3 was prepared from E. coli DH5a(pYS3.3) and tested for bactericidal activity against P. aeruginosa strains as described by Duport et al. (1995) .
RESULTS
Isolation of PVD utilization mutants from type II and type III PVD-producing strains Strain 7NSK2, a plant rhizosphere isolate (Höfte et al., 1990) and type II PVD producer, was chosen because it was easily mutagenized with transposons. For similar reasons, we chose strain 59.20, a clinical isolate and type III PVD producer . Out of 1500 7NSK2 mutants analysed, 50 were found to be unable to grow in the presence of the strong iron chelator EDDHA. Only two of them (7NSK2-8AG5 and 7NSK2-13AB3) were unable to grow in the presence of EDDHA and type II PVD. One of these (7NSK2-13AB3) was still sensitive to pyocin S3, while the other (7NSK2-8AG5) had acquired resistance to pyocin S3. For strain 59.20, 3000 candidates were analysed, and 25 were found to be unable to grow in the presence Meyer, 1997; Goldman & Kranz, 2001 ). Interestingly, mutant 59.20-24A45 had the transposon inserted into a gene with high similarity to ccmB (PA1476), also involved in c-type cytochrome biogenesis, and part of the ccmABCDEFGH operon (Thöny- Meyer, 1997; Goldman & Kranz, 2001) . In this case, the identity was 98 % at the amino acid level between residues 22 and 88 of CcmB.
The 7NSK2 PVD utilization mutant 7NSK2-8AG5 had an insertion in a gene showing similarity (23 identical amino acids out of 25) with the pvdE gene PA2397 (Fig. 1) , upstream of fpvA, encoding an ABC transporter needed for PVD biosynthesis (McMorran et al., 1996) . The 59.20 utilization mutant 59.20-18B3 had an insertion in a gene matching the fpvA gene PA2398 (Fig. 1) .
Physiological characterization of the receptor-negative mutants from P. aeruginosa 7NSK2 and 59.20
The 7NSK2-pvdE mutant failed to produce PVD, became totally resistant to pyocin S3 (results not shown) and failed to grow in CAA in the presence of EDDHA and the cognate PVD (Table 3) . Analysis of outer-membrane proteins by SDS-PAGE shows one iron-repressed outer-membrane protein (IROMP) of 80 kDa missing in the pvdE mutant (results not shown). Uptake of 59
Fe-labelled PVD is completely abolished in the 7NSK2-pvdE mutant (9282±529 c.p.m. incorporated after 5 min for the wild-type vs 54±50 c.p.m. for the pvdE mutant). All these observations confirmed that the pvdE mutant does not produce the type II PVD receptor. Fig. 1 . Schematic representation of the fpvA and pvdE genes in P. aeruginosa strains 7NSK2 (type II PVD) and 59.20 (type III PVD). The positions of the Tn5 insertions are indicated by triangles, and the sequences above are an alignment with the corresponding PAO1 sequence below (http://www. pseudomonas.com). The underlined sequence under the fpvAIII gene represents the translated DNA sequence obtained after subtractive hybridization from a CF epidemic strain (Cheng et al., 1996) . The GenBank accession numbers for the sequences reported in this manuscript are AF537094 (fpvAIII) and AF537095 (fpvAII).
Table 3. Growth of wild-type type II and type III PVD producers and their corresponding mutants
The genes shown in parentheses represent the cognate fpvA in trans. Optical density for all values was measured at 600 nm, and data are the means of three replica cultures in the Bio-Screen; the range of deviation was between 0 and 0?04. Fe-labelled PVD uptake was also strongly reduced in the case of this fpvA mutant (25 960±3142 c.p.m. for the wild-type vs 2068± 467 c.p.m. for the fpvA mutant). Uptake of the other P. aeruginosa siderophore, pyochelin, was unaffected in both mutants (results not shown).
Complementation of the two receptor-negative mutants
A 7NSK2 genomic library was screened using a digoxigeninlabelled fragment corresponding to a partial sequence of fpvAII obtained from the sequence downstream of the interrupted pvdE gene present on the inverse-PCR fragment. The 59.20 library was directly screened in search for a clone complementing the fpvAIII mutation (see Methods). From each library, one cosmid clone (pC7NSK2 from the 7NSK2 library and pC59.20 from the 59.20 library) was selected that, after transfer to the respective 7NSK2-pvdE and 59.20-fpvA mutants, restored the capacity to grow in the presence of EDDHA and the cognate PVD (results not shown). Furthermore, the complemented 7NSK2-pvdE mutant regained pyocin S3 sensitivity (results not shown).
Sequence determination of fpvAII and fpvAIII
Since both pC7NSK2 and pC59.20 complemented all mutant phenotypes, we looked for the fpvAII and fpvAIII genes on the corresponding complementing cosmids. Primers were therefore designed to sequence each fpvA gene directly on cosmid DNA as described in Methods. Briefly, 2848 and 2740 nt fragments containing the fpvAII and fpvAIII ORFs were sequenced from pC7NSK2 and pC59.20, respectively. BLAST searches (Altschul et al., 1997) of FpvAII and FpvAIII peptide sequences against the nr protein database (http://www.ncbi.nlm.nih.gov/) showed that, like FpvAI, these proteins shared 25-31 % identity over the majority of their length with approximately 100 other known or putative TonB-dependent outer-membrane proteins. FpvAII has 808 residues, while FpvAI and FpvAIII have 815. Using the PSI-BLAST algorithm, the highest level of identity was found between FpvAII and a putative TonBdependent receptor (GenBank accession no. AAL45999.1) from Agrobacterium tumefaciens (45 % identity, 60 % similarity), while FpvAIII was most similar (37 % identity, 54 % similarity) to the ferric pseudobactin PbuA receptor from Pseudomonas fluorescens M114 (Morris et al., 1994) .
Unlike FpvAI, FpvAII and FpvIII do not end with a phenylalanine, as is customary, but with a tryptophan in the case of FpvAII and a tyrosine in the case of FpvAIII. However, these are relatively conservative changes and several of the 269 putative TonB-dependent receptor proteins, which make up Pfam TonB_boxC domain alignment (http://pfam.wustl.edu), similarly have terminal tryptophan or tyrosine residues.
Interestingly, analysis of the N-terminal sequences shows that FpvAI has a typical twin-arginine translocase (TAT) secretion signal (RRAF motif), as recently demonstrated by Ochsner et al. (2002a) , while the two other PVD receptors seem rather to have classical secretion signal sequences (results not shown). Finally, analysis of the sequence downstream of fpvaIII showed that the pvdE gene in this case was transcribed in the opposite orientation (Fig. 1) .
Identification of type III fpvA from a cystic fibrosis (CF) epidemic strain by subtractive hybridization Independently from our transposon mutagenesis approach, suppression subtractive hybridization was used to identify genes specific to a P. aeruginosa CF epidemic strain from Liverpool (Cheng et al., 1996; McCallum et al., 2001 McCallum et al., , 2002 Parsons et al., 2002) . One sequence of 341 bp was translated in all six reading frames and one perfect alignment was found with a peptide corresponding to FpvAIII (shown in bold in Fig. 1a) , suggesting a high degree of conservation of fpvAIII.
Peptide sequencing of FpvAII
We used N-terminal sequence analysis and ESI-MS/MS to confirm the identity of the 80 kDa IROMP that was absent from outer-membrane preparations from strain 7NSK2-fpvA (see below). The corresponding band was cut from two SDS-PAGE gels. The N-terminal sequence was XAQKIQFD (where X could not be identified), which corresponds to the sequence EAQKIQFD (residues 44-51) deduced from the translated nucleotide sequence of fpvAII. The band was also subjected to an in-gel tryptic digest prior to internal sequence analysis using ESI-MS/MS. Eight peptides varying between 6 and 15 aa in length were sequenced (results not shown). A total of 86 aa, equalling sequence coverage of 10?6 %, were determined and all matched the deduced amino acid sequence from fpvAII (results not shown).
Generation of 7NSK2 and 59.20 fpvA mutants by allelic exchange and complementation by the respective fpvA genes
The fpvA gene in strains 7NSK2 and 59.20 was inactivated by allelic exchange using a Gm cassette (see Methods). In parallel, both fpvA genes were PCR-amplified and cloned in the broad-host-range plasmid pBBR-1MCS (Kovach et al., 1994) in order to complement the respective fpvA mutants.
Both fpvA mutants had a strongly reduced PVD production, in contrast with the 7NSK2-pvdE mutant, which produced no PVD (results not shown). Fig. 2(a) Complementation by the homologous fpvA gene in trans resulted in both cases in the reappearance (for 7NSK2-fpvA) or much stronger intensity (for 59.20-fpvA) of this particular IROMP on the gel (Fig. 2a, lanes 3 and 6) . It should also be noted that one IROMP, of about 70 kDa, is produced by the mutant 59.20 and the complemented mutant, but not by the wild-type. Fig. 2(b) shows the pyocin S3 sensitivity test for 7NSK2 (panel 1), 7NSK2-fpvA (panel 2) and 7NSK2-fpvA with fpvAII in trans (panel 3). As expected, pyocin S3 sensitivity is restored in the complemented fpvA mutant.
For both strains, growth of the wild-type, fpvA mutant and fpvA mutant with the cognate fpvA gene in trans was measured after 24 and 36 h ( Table 3 ). The different media tested were CAA, CAA plus EDDHA, CAA plus EDDHA and type II PVD, and CAA plus EDDHA and type III PVD. The growth of strain 59.20 was partially inhibited in the presence of EDDHA while this was not the case for 7NSK2, especially when comparing the optical density values after 24 h. The growth of strain 7NSK2 in the presence of EDDHA was strongly stimulated by its cognate PVD, but inhibited by type III PVD, while, unexpectedly, both PVDs stimulated the growth of strain 59.20. Growth of the two fpvA mutants was observed only in CAA medium. The fpvA gene in trans restored growth in the presence of EDDHA partially (59.20-fpvA) or fully (7NSK2-fpvA). Again, type III PVD was inhibitory for the complemented 7NSK2-fpvA mutant during the first 24 h, while type II PVD clearly stimulated the complemented 59.20-fpvA mutant, even after 24 h. After 36 h cultivation, growth of complemented 7NSK2-fpvA was observed in the presence of the heterologous PVD, probably because of restored production of sufficient amounts of the homologous PVD.
The 7NSK2-pvdE mutant could be complemented with fpvAII in trans for growth in the presence of EDDHA only when type II PVD was present in the medium.
Conservation of the different fpvA genes among P. aeruginosa clinical and environmental isolates Primers were developed in order to amplify, from each fpvA, a fragment of different size (326 bp for fpvAI, 897 bp for fpvAII and 506 bp for fpvAIII) using a multiplex PCR setting. Fig. 3 shows the result of a typical PCR amplification, done on P. aeruginosa CF isolates. Out of 21 independent sporadic CF isolates (each with a different PFGE type), 13 were found to contain the gene for fpvAII, five for fpvAI and three for fpvAIII. All isolates from an epidemic strain from Liverpool (Cheng et al., 1996; McCallum et al., 2001 McCallum et al., , 2002 gave amplification of a DNA fragment corresponding to fpvAIII (lane 5, upper gel; lanes 6-10, lower gel). One transmissible strain from Manchester (Jones et al., 2001 ) gave an amplicon corresponding to type II fpvA (lane 11, lower gel). In each case, only one amplicon was observed. 
DISCUSSION
P. aeruginosa is an important nosocomial pathogen as well as the main cause of lung infections among CF patients (Govan & Deretic, 1996; Bodey et al., 1983) . In mouse models, the production of siderophores, particularly PVD, was found to have a major impact on the virulence of this bacterium (Meyer et al., 1996; Takase et al., 2000a Takase et al., , 2000b Handfield et al., 2000) . These reports suggest that PVD-mediated iron uptake could represent an interesting target for drug or vaccine development. The presence of three PVD-receptor-mediated iron uptake systems among P. aeruginosa strains (Cornelis et al., 1989; Meyer et al., 1997; De Vos et al., 2001 ) necessitated the characterization of the two remaining receptors for type II and type III PVDs. Interestingly, type II FpvA is known to be the port of entry for pyocin S3, a P. aeruginosa bacteriocin causing the death of bacteria producing this particular siderophore receptor (Baysse et al., 1999) .
Using transposon mutagenesis, combined with a screening in the presence of EDDHA and the cognate PVD, we were able to obtain mutants unable to utilize these siderophores. Two mutations affecting the utilization of PVDs were found in cytochrome c biogenesis genes (Thöny- Meyer, 1997; Goldman & Kranz, 2001) , ccmB in the case of 59.20, and ccmE in the case of 7NSK2. We have previously shown that mutations in another ccm gene, ccmC, affect the production, maturation and utilization of PVD in P. fluorescens (Gaballa et al., 1996 (Gaballa et al., , 1998 , and that this effect could be due to a reduction in the oxidative power of the periplasm . For each strain, one mutant was obtained that showed defective production of FpvA, as judged by different criteria, but in the case of 7NSK2 the transposon inserted in pvdE, upstream of fpvA. Absence of this gene is the first time that an insertion into pvdE has been shown to affect not only PVD production (McMorran et al., 1996) but also PVD uptake via the FpvA receptor. Complementation of the pvdE mutation with fpvAII in trans was possible only in the presence of the cognate PVD. Probably, the defect in the production of the FpvA receptor in a pvdE mutant is due to the almost complete absence of PVD in the medium and lack of auto-induction of the receptor Visca et al., 2002) . PvdE is a membrane protein of the family of ABC transporters, but its function has been unknown until now (McMorran et al., 1996) . Recently, Ochsner et al. (2002b) demonstrated that fpvA expression depends on a promoter upstream of the gene that contains a binding motif for the alternative sigma factor PvdS needed for the transcription of different PVD biosynthesis genes (Wilson et al., 2001) , confirming earlier observations (McMorran et al., 1996) . This finding seems to exclude the possibility that an insertion into the pvdE gene could have a polar effect on the transcription of fpvA. Furthermore, in the case of fpvAIII, the pvdE gene is transcribed in the opposite orientation (Fig. 1a) .
Although the 59.20-fpvA mutant was clearly deficient for the uptake of its cognate PVD, absence of the corresponding 80 kDa protein could not be unambiguously evidenced by SDS-PAGE. Furthermore, the fpvAIII mutant, whether complemented or not, produces a new IROMP of 70 kDa. It has been shown before that in the absence of PVD production, the profile of IROMPs on SDS-PAGE can be altered (Höfte et al., 1993; Mossialos et al., 2000) . It is therefore possible that other IROMPs, including one of the same molecular mass as FpvAIII, are produced by the fpvAIII mutant. All three receptors have an N-terminal periplasmic extension, also found in other PVD or pseudobactin receptors (Shen et al., 2002) such as PbuA (GenBank accession no. Q08017), PupA (GenBank accession no. P25184) and PupB (GenBank accession no. P38047). This N-terminal domain has recently been shown to interact with another protein, FpvR, an anti-sigma factor that sequesters PvdS Visca et al., 2002) . By interacting with the siderophore, the conformation of the receptor changes, allowing PvdS to be liberated from FpvR . This explains why receptor-negative mutants produce little PVD compared to the wild-type Shen et al., 2002) . Since our fpvAII and fpvAIII mutants also show strongly decreased PVD production, we assume that a similar mechanism is at work in the corresponding P. aeruginosa strains.
An intriguing observation is the capacity of strain 59.20 to utilize, besides its cognate type III PVD, type II PVD, via the FpvAIII receptor. Until recently, it was generally assumed that receptors for PVDs or pseudobactins had a strict specificity for the cognate PVD (Hohnadel & Meyer, 1988; Cornelis et al., 1989) . However, it was found that the receptor for type II P. aeruginosa PVD also recognizes two other PVDs, from P. fluorescens PL7 and PL8 (Meyer et al., 1999 (Meyer et al., , 2002 . The efficiency of the uptake of type II PVD by FpvAIII, if any, must however be low since no significant incorporation of 59 Fe-labelled PVDII by strain 59.20 could be observed (results not shown). Of course, the possibility that PVDII is not taken up via FpvAIII but can interact with the receptor and, by the above-described mechanism, trigger the production of the cognate PVDIII by the strain, thereby promoting growth, cannot be ruled out.
The availability of the three P. aeruginosa fpvA sequences allowed us to look for their conservation among different clinical isolates, using a PCR approach, similar to what was done for the genes encoding the outer-membrane lipoproteins OprI and OprL . A PCR set-up has already been described for the amplification of the fpvA gene corresponding to type I PVD (Al-Samarrai et al., 2000) . Each strain tested so far seems to produce only one single receptor (Fig. 3) . So far, no negative results have been obtained using the multiplex PCR, meaning that the receptors are fairly conserved. This simple test allows the rapid identification of P. aeruginosa isolates that fail to produce PVD, as frequently observed in the case of CF strains (De Vos et al., 2001 ).
In conclusion, the identification of the three PVD receptors characteristic of all P. aeruginosa strains tested so far should help us to identify domains involved in the interaction with the respective PVDs. It will also be interesting in the future to investigate whether FpvAII and FpvAIII, like FpvAI, use the mechanism of PVD-recycling (Folschweiller et al., 2000; Schalk et al., 2001 Schalk et al., , 2002 . Identification of loops interacting with PVD or with pyocin S3 (in the case of FpvAII) is also an interesting goal for coming research. Also, given the importance of PVD for the virulence of P. aeruginosa, and with the perspective of developing a vaccine against this pathogen, identification of protective epitopes would be an important goal to meet.
